Retrospective of Children With ADHD and Cardiac Symptoms

This study has been terminated.
(insufficient number of eligible subjects)
Sponsor:
Information provided by:
Children's Healthcare of Atlanta
ClinicalTrials.gov Identifier:
NCT00266955
First received: December 19, 2005
Last updated: July 5, 2011
Last verified: September 2007
  Purpose

There is some evidence suggesting ADHD medication interaction could result in mild myocardial ischemia/infarct.


Condition
Congenital Disorders

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: A Retrospective Study of Children With ADHD and Cardiac Symptoms

Resource links provided by NLM:


Further study details as provided by Children's Healthcare of Atlanta:

Enrollment: 10
Study Start Date: January 1999
Study Completion Date: September 2007
Detailed Description:

Children with no previous cardiac history who have been on Adderall for ADHD, have developed acute cardiac symptoms after the addition of Straterra for the treatment of ADHD.

We wish to do a study of the medication interactions of Straterra and other ADHD medications focusing on the cardiac manifestations.

We will collect the following information on each patient: Medical Record Number, Account number, Dates of Admission, Discharge, Treatment or Death, Information Regarding Cardiac Signs and Symptoms, Medication Information, Age, Weight, Diagnoses

  Eligibility

Ages Eligible for Study:   up to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

retro chart review

Criteria

Inclusion Criteria:

  • ADHD
  • myocardial ischemia/infarct
  • no previous cardiac history
  • added Straterra
  • already taking Adderall

Exclusion Criteria:

  • those who do not meet inclusion criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00266955

Locations
United States, Georgia
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30322
Sponsors and Collaborators
Children's Healthcare of Atlanta
Investigators
Principal Investigator: Martha Clabby, MD Children's Healthcare of Atlanta
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00266955     History of Changes
Other Study ID Numbers: 04-111
Study First Received: December 19, 2005
Last Updated: July 5, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Children's Healthcare of Atlanta:
pediatric
cardiac
ADHD
Adderall
Straterra

ClinicalTrials.gov processed this record on October 23, 2014